Cargando…
MEDB-32. Reducing treatment-related toxicity for children with WNT-activated medulloblastoma
WNT-medulloblastoma has an excellent prognosis, with an overall survival rate of 90% among children receiving standard-of-care (SOC) surgical resection, radiotherapy, and chemotherapy. Unfortunately, while curative, this treatment is associated with major, long-term, debilitating motor, developmenta...
Autores principales: | Taylor, Jessica, Toker, Joseph, Masih, Katherine, Nathan, Erica, Terranova, Sabrina, Gilbertson, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9165131/ http://dx.doi.org/10.1093/neuonc/noac079.406 |
Ejemplares similares
-
MEDB-33. The landscape of ecDNA in medulloblastoma
por: Chapman, Owen, et al.
Publicado: (2022) -
MEDB-86. A re-induction regimen for children with recurrent medulloblastoma
por: O'Halloran, Katrina, et al.
Publicado: (2022) -
MEDB-27. Clinico-Radiological Outcomes in WNT-pathway Medulloblastoma: Retrospective Single Institutional Audit
por: Mani, Shakthivel, et al.
Publicado: (2022) -
MEDB-01. Management of the risk of medulloblastoma associated to familial adenomatous polyposis and dysregulated Wnt signalosome
por: Abdelmoula, Balkiss, et al.
Publicado: (2022) -
MEDB-31. THE CLINICAL SIGNIFICANCE OF EXTENT OF RESECTION IN MEDULLOBLASTOMA
por: Keeling, Claire, et al.
Publicado: (2022)